Interestingly, the patient tumor, as well as xenografts, expressed CK18, an epithelial marker, and vimentin, a mesenchymal marker (Figure 1), with the stromal portion of the patient tumor, but not the xenograft, also staining positively with the anti-human vimentin antibody. This evidence concerns the gene KRT18 and neoplasm.